DEF 14A: GoHealth, Inc. Announces Details for 2024 Annual Stockholders Meeting

GoHealth, Inc. will hold its 2024 Annual Meeting of Stockholders virtually on June 12, 2024, to vote on the election of directors, ratification of the independent accounting firm, and an advisory vote on executive compensation.

Summary

• GoHealth, Inc. is holding its Annual Meeting of Stockholders on June 12, 2024, at 10:00 a.m. Eastern Daylight Time, as a virtual meeting.
• Stockholders of record as of April 19, 2024, are entitled to vote on the proposals.
• The proposals include the election of Alexander Timm, David Fisher, and Vijay Kotte as Class I Directors, the ratification of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2024, and an advisory vote to approve the compensation of the company's named executive officers.
• The Board of Directors recommends voting for all the proposals.
• The proxy statement and the company's 2023 Annual Report are available to stockholders online.
• As of the record date, there were 50,000 shares of Series A Preferred Stock, 9,944,564 shares of Class A common stock and 12,781,694 shares of Class B common stock outstanding and entitled to vote at the Annual Meeting.

Sentiment

Score: 7

Explanation: The document is a standard proxy statement, presenting information in a neutral and informative tone. The recommendations of the board are positive, but the overall sentiment is balanced and objective.

Positives

• The Board of Directors is actively engaged in corporate governance, with established committees and charters.
• Stockholders have multiple avenues to vote, including online, by phone, and by mail.
• The company provides detailed information on director qualifications and diversity.
• The company has a clawback policy in place to recoup incentive compensation in certain situations.
• The company has adopted a Dodd-Frank Clawback Policy to comply with SEC and Nasdaq listing rules.

Negatives

• The Say-on-Pay Vote is advisory, and therefore not binding on the Company, the Compensation Committee or our Board of Directors.
• The company is a controlled company, which means it is exempt from certain corporate governance standards.
• The compensation committee exercised negative discretion and did not award Annual Bonuses to the NEOs with respect to 2023.

Risks

• The division of the Board of Directors into three classes with staggered three-year terms may delay or prevent a change of management or a change in control of the Company.
• The Stockholders Agreement gives Centerbridge and NVX Holdings significant control over the election of directors.
• As a controlled company, GoHealth is exempt from certain corporate governance requirements, potentially reducing protections for stockholders.
• The company's performance-based RSUs are tied to Adjusted EBITDA CAGR, which may not accurately reflect the company's overall performance or value to shareholders.

Future Outlook

The company will consider the outcome of the Say-on-Pay Vote when determining future executive compensation programs.

Management Comments

• Clinton P. Jones and Brandon M. Cruz, Co-Chairmen of the Board, thanked stockholders for their support.
• The NEOs recommended that the Compensation Committee not award Annual Bonuses to the NEOs under the 2023 Annual Bonus Plan to allow for more funds to be available for Annual Bonuses to be paid to non-NEO employees.

Industry Context

The document does not explicitly discuss broader industry trends, but the focus on virtual meetings and corporate governance practices aligns with current trends in public companies.

Comparison to Industry Standards

• The document does not provide specific comparisons to industry standards.
• However, the discussion of executive compensation, board composition, and audit practices are common topics in proxy statements of publicly traded companies.
• The company's use of a virtual annual meeting is in line with a growing trend among public companies to enhance accessibility and reduce costs.

Management Changes

Corporate Governance

Related Party Transactions

• The company has entered into lease agreements with entities controlled by the Founders, resulting in lease payments of $6 million in 2023.
• Anthem Insurance Companies, Inc., an owner of our Series A Preferred Stock, is a wholly-owned subsidiary of Elevance Health, Inc. (Elevance). Elevance is the owner of health plan partners with which we enter into contractual agency relationships. Health plans owned by Elevance accounted for approximately $142.3 million or 19% of our net revenues for the twelve months ended December 31, 2023.

Stakeholder Impact

• The proposals being voted on will impact shareholders through the election of directors and the approval of executive compensation.
• The ratification of the independent accounting firm ensures the integrity of the company's financial reporting.
• Employees are affected by the executive compensation policies and the overall governance of the company.

Next Steps

• Stockholders are encouraged to vote on the proposals before the Annual Meeting.
• The company will announce preliminary voting results at the Annual Meeting and report the final results in a Form 8-K filing.

Key Dates

Keywords

Annual Meeting, Proxy Statement, Stockholders, Board of Directors, Executive Compensation, Director Election, Ernst & Young, Corporate Governance, GoHealth